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Abstract
Background: In last three years, 96 suspected poultry farms from different provinces in China were diagnosed for
avian infectious bronchitis (IB) survey. Finally, 221 IBV strains were confirmed by dwarf embryo test and RT-PCR
assay. By virus recovery trials, 187 of the isolates caused the birds died or distressed from nephritis, which was
accordant with the clinical record.
Results: Based on epidemiology analysis of recent field isolates of nephropathogenic IB in vaccinated farms in
China, YL6 strain were used for vaccination and evaluated by antibody titer and challenge tests. The
immunoprotection test indicated that the practical application of vaccine based on the recent field strains could
finely facilitate controlling the nephropathogenic IB.
Conclusions: Our study was aim at setting a guide for safeguard against nephropathogenic IBV-caused disease in
China.
Background
Infectious bronchitis (IB) is a serious and highly conta-
gious disease of chickens all over the world. Avian infec-
tious bronchitis virus (IBV) was first reported in the USA
for replicating in the respiratory tract and some other
epithelial cells of gut, kidney, and oviduct. Subsequently,
some strains of IBV caused pathology in non-respiratory
organs (such as kidney and gonads) were documented [1].
The clinical disease and production problems frequently
cause catastrophic economic losses to the poultry industry,
accompanied by decreased production performance in
breeder flocks, diminished egg production and poor egg
quality in laying flocks [1-3]. In China, IB has a more pro-
found social impact for chicken industrial contributes to
the rural economy. More importantly, there is accumulat-
ing evidence that nephropathogenic type IB has been
more and more prevalent in China recently, but the strains
isolated in earlier years mainly caused respiratory signs,
which suggested that selecting and immunization with the
appropriate vaccine strain is of great importance to control
IB infection [4-7].
Some researchers reported that satisfactory cross protec-
tion could be provided by appropriate vaccine programs
against genetically or antigenically unrelated IBVs [8].
However, this symphysial vaccine manner was restricted by
the diversity of the IBV strains. Since IBV strains were first
isolated and identified in China in 1982, various live-atte-
nuated and inactivated vaccines derived from respiratory-
typed strains have been widely and extensively used in
chicken farms to reduce the adverse effect of the IBV [6,7].
However, the disease continues to emerge and cause ser-
ious production problems, even occurred in routinely vac-
cinated layer and breeder flocks in China, and the situation
gets worse as time progressed [9]. The most possible expla-
nation for this phenomenon may be that the vaccine effec-
tiveness is diminished by poor cross-protection against the
circulating strains.
The spike tip glycoprotein (S1) of virus particle has
direct relation to induce virus neutralizing antibody, and
determines the cross-protection [10,11]. Our previous
research had confirmed that the predominant IBVs were
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China during 2008-2009 [4]. This study was to further
investigate the prevalence of nephropathogenic IB under
immune pressure with routine vaccine strains in China.
Additionally, the effectiveness of vaccination program
using the common field strains practically against IB was
also verified.
Results
Isolated IBV strains during 2008 to 2010
From unhealthy birds suspected of IBV infection in the
vaccinated chicken farms from Guangdong, Guangxi,
Fujian, Hainan, Jiangsu, Zhejiang, Chongqing, Hubei,
Sichuan and Jiangxi province of China, 221 filed IBV
strains isolated during 2008-2010 were confirmed by RT-
PCR, including 214 strains isolated from broilers, and 7
strains from broiler breeder. The isolation rates in the
three years were season-dependent to some extent, 58
strains were isolated in early summer (April and May) and
99 strains were isolated in fall and winter (from September
to January). The ages of flocks at the time of the outbreak
varied between 4 and 70 days. Nearly half (110/221) of the
isolated strains were isolated from the chickens between
10 to 30 days of age, seven strains below 10 days, and six
strains above 60 days. Eighty of the 221 isolates have been
molecular analyzized to be mainly A2-like strains [4].
Since the fourth day post-inoculation, most of the chicks
were listless and huddled together, showed appetite and
weight lose. The virus recovery tests indicated 84.6% (187/
221) isolates caused serious kidney lesions, which were
presented with swollen specked kidney and distended
ureters filled with uric acid, and the other isolates caused
respiratory system signs. All the above were consistent
with the clinical record of each strain.
Vaccination test and challenge protection
After the birds were vaccinated, sera were collected and
identified by ELISA, the antibody titer was kept ascending
slowly, on 10 days after the second immunization reached
to a considerable level, even better before challenge, but
none in the control group 4 (unvaccinated but challenged).
As showed in Table 1, there wasn’t obvious discrepancy
in the antibody levels of Group 1, 2 and 3, inoculated with
vaccine XZB and YL6, but much higher than the control
Group 4. The chicks at 24 days old of Group 3 were a bit
higher than Group 1 and 2. Since the second day post
challenge with IBVs, all of the chickens in the four groups
showed transitory and mild respiratory signs, including
tracheal rales, sneezing and coughing. Postmortem exami-
nation of dead and sacrificed birds, revealed the renal
petechial haemorrhages, urates deposition and degenera-
tive changes in renal tubules. While in the chickens of
group 3, there was no morbidity, and all of the clinical
signs of these challenged birds tended to disappear gradu-
ally after two weeks of challenge test (Table 2). Finally, the
birds were validated to be no virus detected by virus isola-
tion through tracheal swabs after three weeks post chal-
lenge. The results of vaccine-challenge trials indicated that
combined immunization with vaccine XZB and YL6 used
in chickens could induce prevention against the infection
of nephropathogenic IBV. The protection effect of XZB
(vaccinated once or twice) was weaker.
After five-month practical application in the field, it
was proved that using the YL6 inactivated vaccine could
basically control the prevalence of nephropathogenic IB,
inducing excellent protection (94%). The broilers and
breeders would not be infected, and the satisfactory
immunity would prevent the hens from lower fertilized
rate, reduced egg quality and laying quantity, and the
progeny chicken could get a high level of maternally
antibodies.
Discussion
Infectious bronchitis (IB) is one of the most common
and difficult-control poultry diseases in China, caused
persistent but infrequent outbreaks in commercial
chicken farms [9,12,13]. The clinical cases caused by
vaccination failure raised the importance to investigate
the circulating nephropathogenic IBVs and select the
candidate vaccine strain against the infections [1,12].
In this study, 221 IBV strains were isolated from the
vaccinated chicken flocks, with a wide age range of IB
outbreak, 51.6% (117/221) of the birds were not older
than 30 days. The chickens infected before the age of 10
days which might be resulted from the maternal antibody
could not provide pertinent protection against the preva-
lent strains. Nowadays, various nephropathogenic strains
of IBV have been identified throughout the world. The
Table 1 Antibody titers before challenge (Mean value)
Group 5 days old 10 days old 17 days old 24 days old
1 2.32 ± 1.242 21.73 ± 7.406 364.41 ± 37.253
a 851.34 ± 58.734
a
2 2.32 ± 1.221 22.75 ± 7.306 477.76 ± 31.132
a 1316.26 ± 87.820
b
3 2.12 ± 1.226 19.69 ± 6.121 471.73 ± 4.436
a 1612.38 ± 69.443
b
4 2.11 ± 1.222 2.63 ± 8.481 2.12 ± 2.855
b 2.23 ± 1.212
c
a, b, c The difference between data with the same letters in the same column is not significant (P > 0.05). The difference between data with different letters in
the same column is significant (P < 0.05).
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blem for chicken industry in China in recent few years
[4,5,7]. Through clinical records and the virus recovery
trials, 187 identified isolates mainly caused typical swol-
len kidney, different from the respiratory type strains iso-
lated in earlier years, including the major vaccine strains.
The vaccine-challenge tests further demonstrated that
chicks vaccinated with currently used vaccines in China
cannot provide sufficient protection against the prevalent
virus strain. The antibody titers evaluated by ELISA were
closely associated with the antigen differences. The com-
plex antigen variations of IB caused the antibody titers
were just referenced, which showed no obvious discre-
pancy between commercial and field vaccine in this study.
The effective of vaccines were dependent on the protec-
tion rate. Absorbingly, the commercial vaccine associated
with the inactivated oil-emulsion vaccine (novel field
strains) can satisfactorily prevent the vaccinated birds
against the infections. The inactivated oil-emulsion vac-
cine (YL6) associated with commercial vaccines have been
used in some flocks, and effectively controlled the sup-
posed IB outburst from 2009 to 2010.
The S1 protein determined the serotypic evolution, the
phenotype change and the genetic diversity of IBVs
[11,14]. The commercial vaccine was consisted of H120
strain and W93 strain, the latter one was nephropatho-
genic strain, but attenuated and started for vaccination in
1990s. The error-prone nature of RNA polymerase made
the S1 gene could easily generate mutations to bring
about new variation strain. Persistent evolutionary varia-
tions caused the distant genetic relationship between the
vaccine strains and the circulating strains. Our previous
report had determined that nephropathogenic IBVs were
mainly A2-like strains in China in recent years, showed
evolutionarily distant from vaccine strains [4].
Conclusions
In conclusion, the data obtained from our study suggested
the satisfactory immunoprotection of the YL6 vaccine,
which genetically belonged to the A2-type group, used in
the southern China. To control the prevalence and well
prepare for the potential outbreaks of IB, the candidate
virus strain for vaccination might be selected timely.
Therefore, continuing surveillance of new IBV strains and
selecting the representative virus strain for vaccination
would be the most effective manner to reduce the eco-
n o m i cl o s s e sc a u s e db yI B .W eh o p et h es t u d yc o u l d
contribute to guiding the development of effective
vaccines and establishment of control policy for nephro-
pathogenic IB.
Materials and methods
Virus isolation and identification
During the period from June 2008 to November 2010, IBV
surveys were performed in 96 suspected but vaccinated
flocks from eastern, southern, southwestern and central
China. Documented clinical signs of the birds included
respiratory and typical nephropathogenic symptoms.
Viruses in the homogenized tissue pool of kidney and tra-
chea of the field isolates were propagated by inoculating
via the allantoic cavity of 10 day old SPF embryonated
eggs for more than three passages. The embryos dying
within 24 hours of inoculation were screened to be non-
specific deaths. The isolates caused stunting, dwarfing,
curling of the embryo or the presence of urates in the
mesonephros after 5 days incubation were indicative of IB
virus replication. The viruses were further confirmed by
RT-PCR assays. The allantoic fluids containing IBV iso-
lates after 72 h post inoculation were harvested and pre-
served in liquid nitrogen.
Total RNA extraction of the allantoic fluid was com-
pleted using RNAiso reagent (TaKaRa Biotechnology,
Dalian, China) according to the manufacturers’ instruc-
tions. Reverse transcription polymerase chain reaction
(RT-PCR) was carried out by PrimeScriptTM One-Step
RT-PCR Kit in 25 μl reaction volume containing 20 μlo f
RT-PCR PreMix (reaction buffer, dNTPs, 2 μlo fe n z y m e
mix), 2 μl of extracted viral RNA and the specific primers
(National standard, GBT23197-2008), one primer pair tar-
geting the M gene (Ms: 5’-CCTAAGAACGGTTGGAAT-
3’,M x :5 ’-TACTCTCTACAC ACACAC-3’)a n da n o t h e r
pair for the 3’ UTR of genome (3’s: 5’-GGAAGATAGG-
CATGTAGCTT-3’,3 ’x: 5’-CTAACTCTATACTAGCC-
TAT-3’).
After IBV confirmation, virus recovery was performed as
previous described [4]. Five 1-day-old SPF White Leghorn
chickens were intranasally inoculated with each isolate,
respectively. All of the chicks were examined and recorded
daily for clinical signs for 20 days post inoculation, the
dead birds were necrospied for lesions of respiratory tract
Table 2 Challenge-vaccination trial program
Group 1
st Vaccination (5 days old) 1
st Vaccination Dose 2
nd Vaccination (10 days old) 2
st Vaccination Dose Death rate (%)
1 H120+W93 0.03 ml
1 PBS 0.2 ml 35
2 H120+W93 0.03 ml H120+W93 0.03 ml 15
3 H120+W93 0.03 ml YL6 0.2 ml 0
4 PBS 0.03 ml PBS 0.2 ml 100
1 Dose per chicken, consist of H120 (10
3.5EID50) and W93 (10
4.7EID50) at least.
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necrospied. All of the animal experiments were conducted
in accordance with the guidelines of Guangdong Province
on the Review of Welfare and Ethics of Laboratory Ani-
mals, and under the protocol (SCAU-AEC-2010-1102)
approved by the Animal Ethics Committee of South China
Agricultural University.
Vaccination-challenge of immunity trials and clinical
application
Based on clinical records and sequence blast from our pre-
vious report, YL6 strain (GenBank accession numbers:
GU938393 for S1 gene) isolated from Yulin city of
G u a n g x ip r o v i n c ei nJ u n e2 0 0 9( w i t hh i g hm o r b i d i t yo f
100% and mortality of 79%) was selected for preparation
of inactivated oil-emulsion vaccine. Ten-day-old SPF
embryonated eggs were inoculated with strain YL6
through five passages to yield a titre of 10
6 to 10
7 median
embryo infectious dose (EID50), which were titrated using
the method described by Liu et al (2006a). The harvested
viruses were inactivated with 2/1000 formaldehyde for 36
h at 37°C, followed by testing for absence of infectivity by
embryo inoculation, adjuvanted with mineral oil in the
ratio of 1 to 2 finally.
Eighty 1-day-old SPF White Leghorn chickens were
housed in biosecurity isolators under quarantine condi-
tions in Wen’s Foodstuff Group Company, and randomly
allocated into 4 groups with 20 birds each. The protection
effect of live attenuated vaccine XZB (Baoite Biopharma-
ceutical Corp. Ltd., Qingdao, China; Commercial vaccine,
consisted of W93 and H120 strain) and YL6 vaccine were
compared through the vaccination-challenge trials. The
birds were inoculated intranasally with routine XZB or
vaccinated intramuscularly with inactivated vaccine YL6.
The detailed vaccination procedures were showed in
Table 2. Group 4 was reared as vaccine-negative control.
Blood samples were collected on day 5, 10, 17 and 24.
Serum antibody titers of 10 randomly selected chickens
from each group were diluted (1: 500) and evaluated with
a commercial total antibody ELISA kit (IDEXX Corpora-
tion, Westbrook, Maine, USA) as described by Liu et al
[15]. Optical density (OD) of each well was read in an
ELISA plate reader at 650 nm. Serum-to-positive ratios
were calculated, using the formula: SP ratio = (OD sam-
ple - OD negative control)/(OD positive control - OD
negative control). From these SP ratios, individual serum
titres were calculated according to the manufacturer’s
instructions.
Challenge test was performed in biosafety-level (BSL)-3
+
lab after the final antibody test to examine whether or not
the novel strain vaccines can provide protective immunity
against the relevant infectious viruses. All of the chickens
at 24 days old were infected by intranasal instillation of
10
5 ×E I D 50 of virulent nephropathogenic HY51 strain
(GenBank accession numbers: GU938386 for S1 gene)
isolated from Heyuan city of Guangdong province (with
high morbidity of 100% and mortality of 76%) in May
2009, the strain was belonged to the IBVs of predominant
genotype [4]. The chicks were examined daily for signs of
infection for 30 days after inoculation. The virus isolation
was carried out through tracheal swabs after three weeks
post challenge.
Sufficient inactivated oil-emulsion vaccine YL6 was
produced as described previously, and applied in some
chicken farms in southern China, including Guangdong,
Guangxi, Guizhou, Fujian and Sichuan province. In the
flocks with epidemic history, the vaccination procedures
were as follows, broilers were inoculated intranasally with
routine XZB at 5 days of age, and vaccinated intramuscu-
larly with 0.2 ml of inactivated vaccine YL6 at 10 days of
age; Broilers were vaccinated intramuscularly with 0.3 ml
of YL6 again at 20 days of age. In the non-epidemic
flocks, broilers were inoculated with routine XZB at 5
days of age, and immunized with 0.2 ml of vaccine YL6
at 10 days of age.
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